Finally Here: Emeprev™ Injectable Gives Your Patients Fast Relief from Vomiting
Veterinarians now have a new ally in managing vomiting in dogs and cats. Dechra has announced FDA approval of Emeprev™ (maropitant citrate) Injectable Solution, the first FDA-approved bioequivalent to the most widely used antiemetic for companion animals. Emeprev™ provides the same trusted effectiveness while introducing features designed to enhance patient comfort and streamline clinic workflows.
One of the standout benefits of Emeprev™ is its preservative. The solution contains benzyl alcohol, which has been shown to act as a local anesthetic, reducing injection pain in dogs. In studies of healthy laboratory dogs, subcutaneous administration of Emeprev™ caused significantly less discomfort compared with the pioneer drug. This means veterinarians can deliver the same reliable antiemetic results with a gentler experience for patients.
Clinic logistics are also simplified with Emeprev™. The injectable solution requires no refrigeration, allowing teams to store and access it more easily while reducing operational complexity. Veterinarians can focus on patient care rather than managing cold storage or juggling multiple formulations.
Emeprev™ is indicated for the prevention and treatment of acute vomiting in dogs and for the treatment of vomiting in cats. It can be administered subcutaneously or intravenously in adult animals, with subcutaneous use for puppies aged 2 to 4 months. Each milliliter contains 10 mg of maropitant citrate along with sulfobutylether-β-cyclodextrin and benzyl alcohol as a preservative. The product is supplied in a 20 mL amber glass vial.
This new injectable solution is all about practical, real-world benefits. Same antiemetic effect, less injection pain, easier storage, and a smooth path to helping patients feel better faster. Emeprev™ is designed for the modern clinic where efficiency, patient comfort, and reliability all matter.
Dechra emphasizes that Emeprev™ is designed to meet real-world clinical needs. With trusted efficacy, a comfort-focused formulation, and simplified storage requirements, it provides veterinary teams with a practical, reliable tool for managing vomiting in dogs and cats. The solution will be available for order through major veterinary distributors in early 2026.
Read the original press release: Click Here
